Molecular Comprehension of Mcl-1: From Gene Structure to Cancer Therapy.


Journal

Trends in cell biology
ISSN: 1879-3088
Titre abrégé: Trends Cell Biol
Pays: England
ID NLM: 9200566

Informations de publication

Date de publication:
07 2019
Historique:
received: 19 02 2019
revised: 14 03 2019
accepted: 19 03 2019
pubmed: 30 4 2019
medline: 2 6 2020
entrez: 30 4 2019
Statut: ppublish

Résumé

Among cell death regulators, members of the Bcl-2 family are of interest because they are highly conserved across species and represent promising targets for anticancer therapy. This family and its associated proteins include more than 25 members, with either anti- or proapoptotic functions. Although the overall regulation of apoptosis by Bcl-2 family proteins is now well understood, targeted therapy requires careful consideration of individual members of the family and their crosstalk. One of the most studied representatives of the Bcl-2 family is antiapoptotic Mcl-1. After 25 years of investigations, a large amount of data regarding Mcl-1's regulation and functions has been compiled. In this review, we summarize current knowledge about Mcl-1, focusing on molecular aspects relevant to Mcl-1-targeted therapies.

Identifiants

pubmed: 31030977
pii: S0962-8924(19)30047-9
doi: 10.1016/j.tcb.2019.03.004
pii:
doi:

Substances chimiques

Antineoplastic Agents 0
MCL1 protein, human 0
Myeloid Cell Leukemia Sequence 1 Protein 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

549-562

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Viacheslav V Senichkin (VV)

Faculty of Medicine, MV Lomonosov Moscow State University, Moscow, Russia.

Alena Y Streletskaia (AY)

Faculty of Medicine, MV Lomonosov Moscow State University, Moscow, Russia.

Boris Zhivotovsky (B)

Faculty of Medicine, MV Lomonosov Moscow State University, Moscow, Russia; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. Electronic address: boris.zhivotovsky@ki.se.

Gelina S Kopeina (GS)

Faculty of Medicine, MV Lomonosov Moscow State University, Moscow, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH